Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse

Frontiers in Pharmacology

Volumn 4 JAN, Issue , 2014, Pages

  Cahill, Emma ^a,b   Salery, Marine ^a,b   Vanhoutte, Peter ^a,b   Caboche, Jocelyne ^a,b  

^a Team Compensation in Neurodegenerative and Aging   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Addiction; Crosstalk; Dopamine; ERK; GPCR; Receptors; Signaling; Striatum

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; METABOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BINDING AFFINITY; BINDING SITE; BRAIN REGION; CORPUS STRIATUM; DISEASE ACTIVITY; DRUG ABUSE; DRUG DEPENDENCE; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84893716496     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00172     Document Type: Review

References (146)

1. Anderson, S. M., Famous, K. R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H. D., Bass, C. E., et al. (2008). CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat. Neurosci. 11, 344-353. doi: 10.1038/nn2054.
2. Ariano, M. A., Wang, J., Noblett, K. L., Larson, E. R., and Sibley, D. R. (1997). Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res. 752, 26-34. doi: 10.1016/S0006-8993(96)01422-9.
3. Bäckström, P., and Hyytiä, P. (2007). Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology 192, 571-580. doi: 10.1007/s00213-007-0753-8.
4. Bateup, H. S., Santini, E., Shen, W., Birnbaum, S., Valjent, E., Surmeier, D. J., et al. (2010). Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc. Natl. Acad. Sci. U.S.A. 7, 14845-14850. doi: 10.1073/pnas.1009874107.
5. Bertran-Gonzalez, J., Bosch, C., Maroteaux, M., Matamales, M., Hervé, D., Valjent, E., et al. (2008). Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J. Neurosci. 28, 5671-5685. doi: 10.1523/JNEUROSCI.1039-08.2008.
6. Besnard, A., Bouveyron, N., Kappes, V., Pascoli, V., Pagès, C., Heck, N., et al. (2011a). Alterations of molecular and behavioral responses to cocaine by selective inhibition of Elk-1 phosphorylation. J. Neurosci. 31, 14296-14307. doi: 10.1523/JNEUROSCI.2890-11.2011.
7. Besnard, A., Galan-Rodriguez, B., Vanhoutte, P., and Caboche, J. (2011b). Elk-1 a transcription factor with multiple facets in the brain. Front. Neurosci. 5:35. doi: 10.3389/fnins.2011.00035.
8. Brami-Cherrier, K., Roze, E., Girault, J.-A., Betuing, S., and Caboche, J. (2009). Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J. Neurochem. 108, 1323-1335. doi: 10.1111/j.1471-4159.2009.05879.x.
9. Brami-Cherrier, K., Valjent, E., Hervé, D., Darragh, J., Corvol, J. C., Pages, C., et al. (2005). Parsing molecular and behavioral effects of cocaine in mitogen-and stress-activated protein kinase-1-deficient mice. J. Neurosci. 25, 11444-11454. doi: 10.1523/JNEUROSCI.1711-05.2005.
10. Caine, S. B., Thomsen, M., Gabriel, K. I., Berkowitz, J. S., Gold, L. H., Koob, G. F., et al. (2007). Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J. Neurosci. 27, 13140-13150. doi: 10.1523/JNEUROSCI.2284-07.2007.
11. Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., et al. (1998). Regulation of cocaine reward by CREB. Science 282, 2272-2275. doi: 10.1126/science.282.5397.2272.
12. Cerovic, M., d'Isa, R., Tonini, R., and Brambilla, R. (2013). Molecular and cellular mechanisms of dopamine-mediated plasticity in the striatum. Neurobiol. Learn. Mem. 105, 63-80. doi: 10.1016/j.nlm.2013.06.013.
13. Cesari, F., Brecht, S., Vintersten, K., Vuong, L. G., Hofmann, M., Klingel, K., et al. (2004). Mice deficient for the ets transcription factor elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol. Cell. Biol. 24, 294-305. doi: 10.1128/MCB.24.1.294-305.2004.
14. Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., et al. (2001). Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4, 873-874. doi: 10.1038/nn0901-873.
15. Choe, E. S., Chung, K. T., Mao, L., and Wang, J. Q. (2002). Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27, 565-575. doi: 10.1016/S0893-133X(02)00341-X.
16. Collins, E. D., Vosberg, S. K., Ward, A. S., Haney, M., and Foltin, R. W. (2007). The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans. Exp. Clin. Psychopharmacol. 15, 228-237. doi: 10.1037/1064-1297.15.3.228.
17. Cui, G., Jun, S. B., Jin, X., Pham, M. D., Vogel, S. S., Lovinger, D. M., et al. (2013). Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494, 238-242. doi: 10.1038/nature11846.
18. Di Chiara, G., and Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85, 5274-5278. doi: 10.1073/pnas.85.14.5274.
19. Dulubova, I., Horiuchi, A., Snyder, G. L., Girault, J. A., Czernik, A. J., Shao, L., et al. (2001). ARPP-16/ARPP-19: a highly conserved family of cAMP-regulated phosphoproteins. J. Neurochem. 77, 229-238. doi: 10.1046/j.1471-4159.2001.t01-1-00191.x.
20. Dunah, A. W., Sirianni, A. C., Fienberg, A. A., Bastia, E., Schwarzschild, M. A., and Standaert, D. G. (2004). Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol. Pharmacol. 65, 121-129. doi: 10.1124/mol.65.1.121.
21. Dunah, A. W., and Standaert, D. G. (2001). Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci. 21, 5546-5558.
22. Engblom, D., Bilbao, A., Sanchis-Segura, C., Dahan, L., Perreau-Lenz, S., Balland, B., et al. (2008). Glutamate receptors on dopamine neurons control the persistence of cocaine seeking. Neuron 59, 497-508. doi: 10.1016/j.neuron.2008.07.010.
23. Everitt, B. J., and Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481-1489. doi: 10.1038/nn1579.
24. Fasano, S., and Brambilla, R. (2011). Ras-ERK signaling in behavior: old questions and new perspectives. Front. Behav. Neurosci. 5:79. doi: 10.3389/fnbeh.2011.00079.
25. Fasano, S., D'Antoni, A., Orban, P. C., Valjent, E., Putignano, E., Vara, H., et al. (2009). Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) controls activation of extracellular signal-regulated kinase (ERK) signaling in the striatum and long-term behavioral responses to cocaine. Biol. Psychiatry 66, 758-768. doi: 10.1016/j.biopsych.2009.03.014.
26. Ferguson, S. M., Fasano, S., Yang, P., Brambilla, R., and Robinson, T. E. (2006). Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 31, 2660-2668. doi: 10.1038/sj.npp.1301014.
27. Ferraguti, F., and Shigemoto, R. (2006). Metabotropic glutamate receptors. Cell Tissue Res. 326, 483-504. doi: 10.1007/s00441-006-0266-5.
28. Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A., et al. (1998). DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838-842. doi: 10.1126/science.281.5378.838.
29. Fiorentini, C., Gardoni, F., Spano, P., Di Luca, M., and Missale, C. (2003). Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J. Biol. Chem. 278, 20196-20202. doi: 10.1074/jbc.M213140200.
30. Fiorentini, C., Rizzetti, M. C., Busi, C., Bontempi, S., Collo, G., Spano, P., et al. (2006). Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. Mol. Pharmacol. 69, 805-812. doi: 10.1124/mol.65.1.121.
31. Fontana, D., Post, R. M., Weiss, S. R. B., and Pert, A. (1993). The role of D1-and D2-dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior. Behav. Pharmacol. 4, 375-387. doi: 10.1097/00008877-199308000-00011.
32. Gerdjikov, T. V., Ross, G. M., and Beninger, R. J. (2004). Place preference induced by nucleus accembens amphetamine is impaired by antagonists of ERK of p38 MAP kinases in rat. Behav. Neurosci. 118, 7405-7750. doi: 10.1037/0735-7044.118.4.740.
33. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., et al. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432. doi: 10.1126/science.2147780.
34. Girault, J. A., Horiuchi, A., Gustafson, E. L., Rosen, N., and Greengard, P. (1990). Differential expression of ARPP-16 and ARPP-19, two highly related cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions. J. Neurosci. 10, 1124-1133.
35. Girault, J. A., Valjent, E., Caboche, J., and Hervé, D. (2007). ERK2: a logical AND gate critical for drug-induced plasticity? Curr. Opin. Pharmacol. 7, 77-85. doi: 10.1016/j.coph.2006.08.012.
36. Haney, M., Ward, A. S., Foltin, R. W., and Fischman, M. W. (2001). Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 155, 330-337. doi: 10.1007/s002130100725.
37. Hara, Y., and Pickel, V. M. (2005). Overlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate NMDA receptors in rat nucleus accumbens. J. Comp. Neurol. 492, 442-455. doi: 10.1002/cne.20740.
38. Hemmings, H. C. Jr., Greengard, P., Tung, H. Y., and Cohen, P. (1984). DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505. doi: 10.1038/310503a0.
39. Hervé, D. (2011). Identification of a specific assembly of the g protein golf as a critical and regulated module of dopamine and adenosine-activated cAMP pathways in the striatum. Front. Neuroanat. 5:48. doi: 10.3389/fnana.2011.00048.
40. Heusner, C., and Palmiter, R. D. (2005). Expression of mutant NMDA receptors in dopamine d1 receptor containing cells prevents cocaine sensitization and decreases cocaine preference. J. Neurosci. 25, 6651-6657. doi: 10.1523/JNEUROSCI.1474-05.2005.
41. Hiroi, N., Fienberg, A. A., Haile, C. N., Alburges, M., Hanson, G. R., Greengard, P., et al. (1999). Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice. Eur. J. Neurosci. 11, 1114-1118. doi: 10.1046/j.1460-9568.1999.00570.x.
42. Hu, J. L., Liu, G., Li, Y. C., Gao, W. J., and Huang, Y. Q. (2010). Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons. Mol. Brain 3, 20. doi: 10.1186/1756-6606-3-20.
43. Huang, Q., Zhou, D., Chase, K., Gusella, J. F., Aronin, N., and DiFiglia, M. (1992). Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre-and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl. Acad. Sci. U.S.A. 89, 11988-11992. doi: 10.1073/pnas.89.24.11988.
44. Hyman, S. E., Malenka, R. C., and Nestler, E. J. (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565-598. doi: 10.1146/annurev.neuro.29.051605.113009.
45. Ibba, F., Vinci, S., Spiga, S., Peana, A. T., Assaretti, A. R., Spina, L., et al. (2009). Ethanol-induced extracellular signal regulated kinase: role of dopamine D1 receptors. Alcohol. Clin. Exp. Res. 33, 858-867. doi: 10.1111/j.1530-0277.2009.00907.x.
46. Kalivas, P. W. (2009). The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 10, 561-572. doi: 10.1038/nrn2515.
47. Kampman, K. M., Dackis, C., Lynch, K. G., Pettinati, H., Tirado, C., Gariti, P., et al. (2006). A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend. 85, 129-137. doi: 10.1016/j.drugalcdep.2006.04.002.
48. Kampman, K. M., Dackis, C., Pettinati, H. M., Lynch, K. G., Sparkman, T., and O'Brien, C. P. (2011). A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence. Addict. Behav. 36, 217-221. doi: 10.1016/j.addbeh.2010.11.003.
49. Karler, R., Calder, L. D., Chaudhry, I. A., and Turkanis, S. A. (1989). Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45, 599-606. doi: 10.1016/0024-3205(89)90045-3.
50. Kebabian, J. W., and Calne, D. B. (1979). Multiple receptors for dopamine. Nature 277, 93-96. doi: 10.1038/277093a0.
51. Kelley, A. E. (2004). Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44, 161-179. doi: 10.1016/j.neuron.2004.09.016.
52. Kenny, P. J., Boutrel, B., Gaspatini, F., Koob, G. F., and Markou, A. (2005). Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology 179, 247-254. doi: 10.1007/s00213-004-2069-2.
53. Kenny, P. J., Paterson, N. E., Boutrel, B., Semenova, S., Harrison, A. A., Gasparini, F., et al. (2003). Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann. N. Y. Acad. Sci. 1003, 415-418. doi: 10.1196/annals.1300.040.
54. Kleckner, N. W., and Dingledine, R. (1988). Requirement for glycine in activation ofNMDA-receptors expressed in Xenopus oocytes. Science 241, 835-837. doi: 10.1126/science.2841759.
55. Köhr, G., and Seeburg, P. H. (1996). Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family. J. Physiol. 492, 445-452.
56. Krapivinsky, G., Krapivinsky, L., Manasian, Y., Ivanov, A., Tyzio, R., Pellegrino, C., et al. (2003). The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and Ras-GRF1. Neuron 40, 775-784. doi: 10.1016/S0896-6273(03)00645-7.
57. Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., et al. (2010). Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622-626. doi: 10.1038/nature09159.
58. Kumaresan, V., Yuan, M., Yee, J., Famous, K. R., Anderson, S. M., Schmidt, H. D., et al. (2009). Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming and cue-induced reinstatement of cocaine seeking. Behav. Brain Res. 14, 238-244. doi: 10.1016/j.bbr.2009.03.039.
59. Kunii, Y., Hyde, T. M., Ye, T., Li, C., Kolachana, B., Dickinson, D., et al. (2013). Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression. Mol. Psychiatry doi: 10.1038/mp.2012.174 [Epub ahead of print].
60. Lau, C. G., and Zukin, R. S. (2007). NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8, 413-426. doi: 10.1038/nrn2153.
61. Laube, B., Hirai, H., Sturgess, M., Betz, H., and Kuhse, J. (1997). Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18, 493-503. doi: 10.1016/S0896-6273(00)81249-0.
62. Lavaur, J., Bernard, F., Trifilieff, P., Pascoli, V., Kappes, V., Pagès, C., et al. (2007). A TAT-DEF-Elk-1 peptide regulates the cytonuclear trafficking of Elk-1 and controls cytoskeleton dynamics. J. Neurosci. 27, 14448-14458. doi: 10.1523/JNEUROSCI.2279-07.2007.
63. Le Moine, C., and Bloch, B. (1995). D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355, 418-426. doi: 10.1002/cne.903550308.
64. Lee, B., Platt, D. M., Rowlett, J. K., Adewale, A. S., and Spealman, R. D. (2005). Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J. Pharmacol. Exp. Ther. 312, 1232-1240. doi: 10.1124/jpet.104.078733.
65. Lee, F. J. S., Xue, S., Pei, L., Vukusic, B., Chéry, N., Wang, Y., et al. (2002). Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111, 219-230. doi: 10.1016/S0092-8674(02)00962-5.
66. Leonard, A. S., and Hell, J. W. (1997). Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272, 12107-12115. doi: 10.1074/jbc.272.18.12107.
67. Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., et al. (1992). Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. U.S.A. 89, 8155-8159. doi: 10.1073/pnas.89.17.8155.
68. Liu, X. Y., Chu, X. P., Mao, L. M., Wang, M., Lan, H. X., Li, M. H., et al. (2006). Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52, 897-909. doi: 10.1016/j.neuron.2006.10.011.
69. Lobo, M. K., and Nestler, E. J. (2011). The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front. Neuroanat. 5:41. doi: 10.3389/fnana.2011.00041.
70. Lohse, M. J., Nikolaev, V. O., Hein, P., Hoffmann, C., Vilardaga, J. P., and Bunemann, M. (2008). Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol. Sci. 29, 159-165. doi: 10.1016/j.tips.2007.12.002.
71. Mao, L., and Wang, J. Q. (2000). Distinct inhibition of acute cocaine-stimulated motor activity following microinjection of a group III metabotropic glutamate receptor agonist into the dorsal striatum of rats. Pharmacol. Biochem. Behav. 67, 93-101. doi: 10.1016/S0091-3057(00)00307-5.
72. Mardikian, P. N., LaRowe, S. D., Hedden, S., Kalivas, P. W., and Malcolm, R. J. (2007). An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 389-394. doi: 10.1016/j.pnpbp.2006.10.001.
73. Mayer, M. L., Westbrook, G., and Guthrie, P. B. (1984). Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 309, 261-263. doi: 10.1038/309261a0.
74. Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., et al. (2002). Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34, 807-820. doi: 10.1016/S0896-6273(02)00716-X.
75. Menniti, F. S., Faraci, W. S., and Schmidt, C. J. (2006). Phosphodiesterases in the CNS: targets for drug development. Nat. Rev. Drug Discov. 5, 660-670. doi: 10.1038/nrd2058.
76. Miller, C. A., and Marshall, J. F. (2005). Molecular substrates for retrieval and reconsolidation of cocaine-associated contextual memory. Neuron 47, 873-884. doi: 10.1016/j.neuron.2005.08.006.
77. Miner, L. L., Drago, J., Chamberlain, P. M., Donovan, D., and Uhl, G. R. (1995). Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport 6, 2314-2316. doi: 10.1097/00001756-199511270-00011.
78. Missale, C., Nash, S. R., Robinson, S. W., Jaber, M., and Caron, M. G. (1998). Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
79. Mitrano, D. A., and Smith, Y. (2007). Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey. J. Comp. Neurol. 500, 788-806. doi: 10.1002/cne.21214.
80. Mothet, J. P., Parent, A. T., Wolosker, H., Brady, R. O., Linden, D. J., Ferris, C. D., et al. (2000). D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A. 97, 4926-4931. doi: 10.1073/pnas.97.9.4926.
81. Nai, Q., Li, S., Wang, S. H., Liu, J., Lee, F. J. S., Frankland, P. W., et al. (2010). Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory. Biol. Psychiatry 67, 246-254. doi: 10.1016/j.biopsych.2009.08.011.
82. Nakazawa, T., Komai, S., Tezuka, T., Hisatsune, C., Umemori, H., Semba, K., et al. (2001). Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 276, 693-699. doi: 10.1074/jbc.M008085200.
83. Nestler, E. J. (2004). Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25, 210-218. doi: 10.1016/j.tips.2004.02.005.
84. Neve, K. A., Seamans, J. K., and Trantham-Davidson, H. (2004). Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165-205. doi: 10.1081/RRS-200029981.
85. Niswender, C. M., and Conn, P. J. (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295-322. doi: 10.1146/annurev.pharmtox.011008.145533.
86. Nguyen, T. H., Liu, J., and Lombroso, P. J. (2002). Striatal enriched phosphatase 61 dephosphorylates Fyn at phosphotyrosine 420. J. Biol. Chem. 277, 24274-24279. doi: 10.1074/jbc.M111683200.
87. Nishi, A., Snyder, G. L., Nairn, A. C., and Greengard, P. (1999). Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J. Neurochem. 72, 2015-2021. doi: 10.1046/j.1471-4159.1999.0722015.x.
88. Pascoli, V., Besnard, A., Hervé, D., Pagès, C., Heck, N., Girault, J.-A., et al. (2011a). Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. Biol. Psychiatry 69, 218-227. doi: 10.1016/j.biopsych.2010.08.031.
89. Pascoli, V., Turiault, M., and Lüscher, C. (2011b). Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature 481, 71-75. doi: 10.1038/nature10709.
90. Paul, S., Snyder, G. L., Yokakura, H., Picciotto, M. R., Nairn, A. C., and Lombroso, P. J. (2000). The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci. 20, 5630-5638.
91. Pei, L., Lee, F. J. S., Moszczynska, A., Vukusic, B., and Liu, F. (2004). Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J. Neurosci. 24, 1149-1158. doi: 10.1523/JNEUROSCI.3922-03.2004.
92. Perroy, J., Raynaud, F., Homburger, V., Rousset, M. C., Telley, L., Bockaert, J., et al. (2008). Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. J. Biol. Chem. 283, 6799-6805. doi: 10.1074/jbc.M705661200.
93. Pierce, R. C., Bell, K., Duffy, P., and Kalivas, P. W. (1996). Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16, 1550-1560.
94. Platt, D. M., Rowlett, J. K., and Spealman, R. D. (2008). Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine. Psychopharmacology 200, 167-176. doi: 10.1007/s00213-008-1191-y.
95. Pulido, R., Zúñiga, A., and Ullrich, A. (1998). PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17, 7337-7350. doi: 10.1093/emboj/17.24.7337.
96. Ramsey, A. J., Laakso, A., Cyr, M., Sotnikova, T. D., Salahpour, A., Medvedev, I. O., et al. (2008). Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology 33, 2701-2714. doi: 10.1038/sj.npp.1301663.
97. Rivera, A., Alberti, I., Martin, A. B., Narvaez, J. A., De la Calle, A., and Moratalla, R. (2002). Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype. Eur. J. Neurosci. 16, 2049-2058. doi: 10.1046/j.1460-9568.2002.02280.x.
98. Robbins, T., and Everitt, B. J. (2002). Limbic-striatal memory systems and drug addiction. Neurobiol. Learn. Mem. 78, 625-636. doi: 10.1006/nlme.2002.4103.
99. Robinson, A. J., and Nestler, E. J. (2011). Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 12, 623-637. doi: 10.1038/nrn3111.
100. Romach, M. K., Glue, P., Kampman, K., Kaplan, H. L., Somer, G. R., Poole, S., et al. (1999). Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166). Arch. Gen. Psychiatry 56, 1101-1106. doi: 10.1001/archpsyc.56.12.1101.
101. Salter, M. W., and Kalia, L. V. (2004). Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 5, 317-328. doi: 10.1038/nrn1368.
102. Salzmann, J., Marie-Claire, C., Le Guen, S., Roques, B. P., and Noble, F. (2003). Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br. J. Pharmacol. 140, 831-838. doi: 10.1038/sj.bjp.0705506.
103. Schenk, S., Valadez, A., McNamara, C., House, D. T., Higley, D., Bankson, M. G., et al. (1993). Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology 111, 332-338. doi: 10.1007/BF02244949.
104. Schiffmann, S. N., Lledo, P. M., and Vincent, J. D. (1995). Dopamine D1 receptor modulates the voltage-gated sodium current in rat striatal neurones through a protein kinase A. J. Physiol. 483, 95-107.
105. Schoepp, D. D., and Conn, P. J. (1993). Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14, 13-20. doi: 10.1016/0165-6147(93)90107-U.
106. Schultz, W. (2010). Dopamine signals for reward value and risk: basic and recent data. Behav. Brain Funct. 6, 24. doi: 10.1186/1744-9081-6-24.
107. Schumann, J., and Yaka, R. (2009). Prolonged withdrawal from repeated noncontingent cocaine exposure increases NMDA receptor expression and ERK activity in the nucleus accumbens. J. Neurosci. 29, 6955-6963. doi: 10.1523/JNEUROSCI.1329-09.2009.
108. Scott, D. B., Blanpied, T. A., Swanson, G. T., Zhang, C., and Ehlers, M. D. (2001). An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J. Neurosci. 21, 3063-3072.
109. Scott, L., Zelenin, S., Malmersjö, S., Kowalewski, J. M., Markus, E. Z., Nairn, A. C., et al. (2006). Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines. Proc. Natl. Acad. Sci. U.S.A. 103, 762-767. doi: 10.1073/pnas.0505557103.
110. Sgambato, V., Vanhoutte, P., Pages, C., Rogard, M., Hipskind, R., Besson, M. J., et al. (1998). In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J. Neurosci. 18, 214-226.
111. Smiley, J. F., Levey, A. I., Ciliax, B. J., and Goldman-Rakic, P. S. (1994). D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. U.S.A. 91, 5720-5724. doi: 10.1073/pnas.91.12.5720.
112. Smith, R. J., Lobo, M. K., Spencer, S., and Kalivas, P. W. (2013). Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). Curr. Opin. Neurobiol. 23, 546-552. doi: 10.1016/j.conb.2013.01.026.
113. Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., et al. (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051-1058. doi: 10.1038/nn1503.
114. Snyder, G. L., Fienberg, A. A., Huganir, R. L., and Greengard, P. (1998). A dopamine/D1 receptor/protein kinase A/dopamine-and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18, 10297-10303.
115. Stipanovich, A., Valjent, E., Matamales, M., Nishi, A., Ahn, J. H., Maroteaux, M., et al. (2008). A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature 453, 879-884. doi: 10.1038/nature06994.
116. Sun, W. L., Zhou, L., Quinones-Jenab, V., and Jenab, S. (2009). Cocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats. Brain Res. Bull. 80, 377-381. doi: 10.1016/j.brainresbull.2009.08.016.
117. Surmeier, D. J., Bargas, J., Hemmings, H. C., Nairn, A. C., and Greengard, P. (1995). Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14, 385-397. doi: 10.1016/0896-6273(95)90294-5.
118. Tezuka, T., Umemori, H., Akiyama, T., Nakanishi, S., and Yamamoto, T. (1999). PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc. Natl. Acad. Sci. U.S.A. 96, 435-440. doi: 10.1073/pnas.96.2.435.
119. Tingley, W. G., Ehlers, M. D., Kameyama, K., Doherty, C., Ptak, J. B., Riley, C. T., et al. (1997). Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J. Biol. Chem. 272, 5157-5166. doi: 10.1074/jbc.272.8.5157.
120. Trifilieff, P., Lavaur, J., Pascoli, V., Kappes, V., Brami-Cherrier, K., Pages, C., et al. (2009). Endocytosis controls glutamate-induced nuclear accumulation of ERK. Mol. Cell. Neurosci. 41, 325-336. doi: 10.1016/j.mcn.2009.04.006.
121. Valjent, E., Bertran-Gonzalez, J., Aubier, B., Greengard, P., Hervé, D., and Girault, J. A. (2010). Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol. 35, 401-415. doi: 10.1038/npp.2009.143.
122. Valjent, E., Corvol, J. C., Pages, C., Besson, M. J., Maldonado, R., and Caboche, J. (2000). Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701-8709.
123. Valjent, E., Corvol, J. C., Trzaskos, J. M., Girault, J. A., and Hervé, D. (2006a). Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci. 7:20. doi: 10.1186/1471-2202-7-20.
124. Valjent, E., Corbillé, A. G., Bertran-Gonzalez, J., Hervé, D., and Girault, J. A. (2006b). Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc. Natl. Acad. Sci. U.S.A. 103, 2932-2937. doi: 10.1073/pnas.0511030103.
125. Valjent, E., Pagès, C., Hervé, D., Girault, J. A., and Caboche, J. (2004). Addictive and non-addictive drug induce dinstinct and specific pattern of ERK activation in mouse brain. Eur. J. Neurosci. 19, 1826-1836. doi: 10.1111/j.1460-9568.2004.03278.x.
126. Valjent, E., Pagès, C., Rogard, M., Besson, M. J., Maldonado, R., and Caboche, J. (2001). Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci. 14, 342-352. doi: 10.1046/j.0953-816x.2001.01652.x.
127. Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., et al. (2005). Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U.S.A. 102, 491-496. doi: 10.1073/pnas.0408305102.
128. Vezina, P., and Queen, A. L. (2000). Induction of locomotor sensitizationby amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology 151, 184-191. doi: 10.1007/s002130000463.
129. Walaas, S. I., Aswad, D. W., and Greengard, P. (1983). A dopamine-and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69-71. doi: 10.1038/301069a0.
130. Walaas, S. I., Cala, S., and Greengard, P. (1989). Localization of ARPP-90, a major 90 kiloDalton basal ganglion-enriched substrate for cyclic AMP-dependent protein kinase, in striatonigral neurons in the rat brain. Brain Res. Mol. Brain Res. 5, 149-157. doi: 10.1016/0169-328X(89)90006-5.
131. Walaas, S. I., and Greengard, P. (1993). ARPP-39, a membrane-associated substrate for cyclic AMP-dependent protein kinase present in neostriatal neurons. J. Mol. Neurosci. 4, 73-88. doi: 10.1007/BF02782120.
132. Walaas, S. I., Hemmings, H. C., Greengard, P., and Nairn, A. C. (2011). Beyond the dopamine receptor: regulation and roles of serine/threonine protein phosphatases. Front. Neuroanat. 5:50. doi: 10.3389/fnana.2011.00050.
133. White, F. J., Joshi, A., Koeltzow, T. E., and Hu, X. T. (1998). Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18, 26-40. doi: 10.1016/S0893-133X(97)00093-6.
134. Wickens, J. R. (2009). Synaptic plasticity in the basal ganglia. Behav. Brain Res. 199, 119-128. doi: 10.1016/j.bbr.2008.10.030.
135. Winhusen, T., Somoza, E., Sarid-Segal, O., Goldsmith, R. J., Harrer, J. M., Coleman, F. S., et al. (2007). A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence. Drug Alcohol Depend. 91, 205-212. doi: 10.1016/j.drugalcdep.2007.05.021.
136. Wise, R. A., and Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492. doi: 10.1037/0033-295X.94.4.469.
137. Wittmann, M., Marino, M. J., Henze, D. A., Seabrook, G. R., and Conn, P. J. (2005). Clozapine potentiation of N-Methyl-D-aspartate receptor currents in the nucleus accumbens?: role of NR2B and protein kinase A/Src kinases. J. Pharmacol. Exp. Ther. 313, 594-603. doi: 10.1124/jpet.104.080200.
138. Wolf, M. E. (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720. doi: 10.1016/S0301-0082(97)00090-7.
139. Woods, A. S., Ciruela, F., Fuxe, K., Agnati, L. F., Lluis, C., Franco, R., et al. (2005). Role of electrostatic interaction in receptor-receptor heteromerization. J. Mol. Neurosci. 26, 125-132. doi: 10.1385/JMN:26:2-3:125.
140. Xu, M., Guo, Y., Vorhees, C. V., and Zhang, J. (2000). Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res. 852, 198-207. doi: 10.1016/S0006-8993(99)02258-1.
141. Xu, M., Hu, X. T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., et al. (1994). Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutantmice. Cell 79, 945-955. doi: 10.1016/0092-8674(94)90026-4.
142. Yaka, R., He, D. Y., Phamluong, K., and Ron, D. (2003). Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J. Biol. Chem. 278, 9630-9638. doi: 10.1074/jbc.M209141200.
143. Yaka, R., Thornton, C., Vagts, A. J., Phamluong, K., Bonci, A., and Ron, D. (2002). NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1. Proc. Natl. Acad. Sci. U.S.A. 99, 5710-5715. doi: 10.1073/pnas.062046299.
144. Young, M. J., Sisti, D. A., Rimon-Greenspan, H., Schwartz, J. L., and Caplan, A. L. (2012). Immune to addiction: the ethical dimensions of vaccines against substance abuse. Nat. Immunol. 13, 521-524. doi: 10.1038/ni.2321.
145. Zhang, Y., Loonam, T. M., Noailles, P. H., and Angulo, J. A. (2001). Comparison of cocaine-and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann. N. Y. Acad. Sci. 937, 93-120. doi: 10.1111/j.1749-6632.2001.tb03560.x.
146. Zweifel, L. S., Argilli, E., Bonci, A., and Palmiter, R. D. (2008). Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 59, 486-496. doi: 10.1016/j.neuron.2008.05.028.